tetradecanoylphorbol acetate has been researched along with Macular Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soboleva, GM; Sukhikh, GT | 1 |
| Gillies, MC; King, NJ; Madigan, MC; Penfold, PL; Provis, JM; Wen, L | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and Macular Degeneration
| Article | Year |
|---|---|
Sorsby fundus dystrophy-related mutation in tissue inhibitor of metalloproteinases-3 impairs regulation of its expression in mouse fibroblasts.
Topics: Animals; Cell Differentiation; Cell Nucleus; Cell Shape; Cells, Cultured; Dexamethasone; Fibroblasts; Fundus Oculi; Macular Degeneration; Mice; Mice, Mutant Strains; Mitogens; Mutation; Tetradecanoylphorbol Acetate; Tissue Inhibitor of Metalloproteinase-3 | 2007 |
Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration.
Topics: Animals; Anti-Inflammatory Agents; Blood-Retinal Barrier; Cell Line; Cell Membrane Permeability; Epithelial Cells; Histocompatibility Antigens Class I; Humans; Intercellular Adhesion Molecule-1; Macular Degeneration; Microscopy, Electron; Tetradecanoylphorbol Acetate; Triamcinolone Acetonide | 2000 |